Synthetic DNA Vectors and Methods of Use
Summary
The European Patent Office published patent application EP3765023A1 for Aldevron LLC covering synthetic DNA vectors and their methods of use. The patent relates to genetic engineering applications with IPC classifications in pharmaceutical compositions (A61K) and molecular biology methods (C12N). The application designates all European member states as covered jurisdictions.
What changed
The EPO published patent EP3765023A1 for Aldevron LLC titled 'Synthetic DNA Vectors and Methods of Use.' The patent covers genetic engineering vectors and methodologies, with inventors SCHNEPP and JOHNSON. The application received an A1 publication type indicating a published European patent application with search report. The designated states cover major European markets including DE, FR, GB, IT, ES, NL, and 27 additional EPC contracting states.
This is a routine patent publication notification with no compliance obligations for third parties. Organizations developing genetic engineering, gene therapy, or synthetic biology products should review this patent to assess potential licensing requirements or freedom-to-operate considerations. Patent monitoring services should flag this publication for IP clearance analysis if relevant to ongoing research programs.
Source document (simplified)
SYNTHETIC DNA VECTORS AND METHODS OF USE
Publication EP3765023A1 Kind: A1 Mar 25, 2026
Applicants
Aldevron, LLC
Inventors
SCHNEPP, Bruce, C., JOHNSON, Philip, R.
IPC Classifications
A61K 31/513 20060101AFI20211213BHEP A61K 48/00 20060101ALI20211213BHEP C12N 15/85 20060101ALI20211213BHEP A61K 31/711 20060101ALI20211213BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.